IL146442A0 - Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy - Google Patents
Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapyInfo
- Publication number
- IL146442A0 IL146442A0 IL14644200A IL14644200A IL146442A0 IL 146442 A0 IL146442 A0 IL 146442A0 IL 14644200 A IL14644200 A IL 14644200A IL 14644200 A IL14644200 A IL 14644200A IL 146442 A0 IL146442 A0 IL 146442A0
- Authority
- IL
- Israel
- Prior art keywords
- sup
- group
- hydrogen atom
- hydroxyl
- therapy
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title abstract 2
- -1 Steroid compounds Chemical class 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000004419 alkynylene group Chemical group 0.000 abstract 1
- 230000000125 calcaemic effect Effects 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9910934.0A GB9910934D0 (en) | 1999-05-11 | 1999-05-11 | Chemical compounds |
| PCT/GB2000/001813 WO2000068246A1 (en) | 1999-05-11 | 2000-05-11 | Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL146442A0 true IL146442A0 (en) | 2002-07-25 |
Family
ID=10853250
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14644200A IL146442A0 (en) | 1999-05-11 | 2000-05-11 | Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| IL146442A IL146442A (en) | 1999-05-11 | 2001-11-11 | Steroid compounds with C17-alkyl side chain and aromatic ring A for use in healing |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL146442A IL146442A (en) | 1999-05-11 | 2001-11-11 | Steroid compounds with C17-alkyl side chain and aromatic ring A for use in healing |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6881730B1 (cs) |
| EP (1) | EP1179005B1 (cs) |
| JP (1) | JP2002544137A (cs) |
| KR (1) | KR100690040B1 (cs) |
| CN (1) | CN1158297C (cs) |
| AT (1) | ATE254629T1 (cs) |
| AU (1) | AU779743B2 (cs) |
| CA (1) | CA2373443A1 (cs) |
| CZ (1) | CZ297316B6 (cs) |
| DE (1) | DE60006665T2 (cs) |
| DK (1) | DK1179005T3 (cs) |
| ES (1) | ES2207509T3 (cs) |
| GB (1) | GB9910934D0 (cs) |
| HK (1) | HK1046001B (cs) |
| HU (1) | HUP0201047A3 (cs) |
| IL (2) | IL146442A0 (cs) |
| NO (1) | NO319949B1 (cs) |
| NZ (1) | NZ515482A (cs) |
| PT (1) | PT1179005E (cs) |
| WO (1) | WO2000068246A1 (cs) |
| ZA (1) | ZA200109272B (cs) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| GB9910934D0 (en) * | 1999-05-11 | 1999-07-14 | Res Inst Medicine Chem | Chemical compounds |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| KR100740354B1 (ko) * | 2000-05-11 | 2007-07-26 | 리서치 인스티튜트 포 메디신 앤드 케미스트리 인코포레이티드 | 2-치환된 프레그나-1,3,5(10)-트리엔 및콜라-1,3,5(10)-트리엔 유도체 및 그의 생물학적 활성 |
| US6995278B2 (en) | 2000-08-18 | 2006-02-07 | Entre Med, Inc. | Antiangiogenic agents |
| US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
| WO2002042319A2 (en) * | 2000-11-27 | 2002-05-30 | Entremed, Inc. | 2-substituted estrogens as antiangiogenic agents |
| WO2002092100A1 (en) * | 2001-05-11 | 2002-11-21 | Marsden, John, Christopher | 17-(c(ch3) (ch2) o-3c (r4, r5) n (r6, r7))-substituted 19-nor-pregna-1, 3, 5(10)-triene derivatives and their medical use |
| US7371741B2 (en) | 2003-05-28 | 2008-05-13 | Entremed, Inc. | Estradiol derivatives and pharmaceutical compositions using same |
| AU2005222934B2 (en) | 2004-03-12 | 2010-06-17 | Entremed, Inc. | Antiangiogenic agents |
| WO2007109312A2 (en) | 2006-03-20 | 2007-09-27 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
| KR101598402B1 (ko) * | 2007-06-19 | 2016-03-03 | 키쎄라 바이오파마슈티컬즈 인코포레이티드 | 합성 담즙산 조성물, 방법 및 제조물 |
| US8242294B2 (en) | 2007-06-19 | 2012-08-14 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| US20080318870A1 (en) | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| JOP20180077A1 (ar) | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
| HUE062616T2 (hu) | 2011-09-08 | 2023-11-28 | Sage Therapeutics Inc | Neuroaktív szteroidok, készítmények és alkalmazásaik |
| LT2968369T (lt) | 2013-03-13 | 2018-12-27 | Sage Therapeutics, Inc. | Neuroaktyvūs steroidai ir jų panaudojimo būdai |
| EP4306114A1 (en) | 2014-06-18 | 2024-01-17 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| SI3319612T1 (sl) | 2015-07-06 | 2021-11-30 | Sage Therapeutics, Inc. | Oksisteroli in postopki za uporabo le-teh |
| US10696712B2 (en) | 2015-07-06 | 2020-06-30 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| MD3319611T2 (ro) | 2015-07-06 | 2021-06-30 | Sage Therapeutics Inc | Oxisteroli și metode de utilizare a acestora |
| US20190330259A1 (en) | 2016-04-01 | 2019-10-31 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| WO2017193046A1 (en) | 2016-05-06 | 2017-11-09 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| PL3481846T3 (pl) | 2016-07-07 | 2021-12-20 | Sage Therapeutics, Inc. | 11-podstawione 24-hydroksysterole do stosowania w leczeniu stanów związanych z NMDA |
| CN110023323A (zh) | 2016-09-30 | 2019-07-16 | 萨奇治疗股份有限公司 | C7取代的氧固醇及其作为nmda调节剂的方法 |
| MX2019004578A (es) | 2016-10-18 | 2019-10-09 | Sage Therapeutics Inc | Oxisteroles y metodos de uso de los mismos. |
| IL293231B1 (en) | 2016-10-18 | 2025-06-01 | Sage Therapeutics Inc | Oxysterols and methods of use thereof |
| CN115040524A (zh) * | 2022-07-27 | 2022-09-13 | 深圳市中西医结合医院 | 4-胆甾烯-3-酮用于治疗多发性骨髓瘤骨病的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3562260A (en) * | 1965-08-23 | 1971-02-09 | Ormonoterapia Richter Spa | 2-carbonyl-estratrienes and method of their preparation |
| GB1267915A (en) * | 1968-05-24 | 1972-03-22 | Glaxo Lab Ltd | Ring a-substituted ring a-aromatic steroids |
| FR2528434B1 (fr) * | 1982-06-11 | 1985-07-19 | Roussel Uclaf | Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament |
| JP2623285B2 (ja) * | 1988-03-09 | 1997-06-25 | 雪印乳業株式会社 | ２（３―ハイドロキシ―１，３，５（１０）―エストリエン―１７―イル）プロピオン酸の製造法 |
| GB9910934D0 (en) * | 1999-05-11 | 1999-07-14 | Res Inst Medicine Chem | Chemical compounds |
| US6967195B2 (en) * | 2000-05-11 | 2005-11-22 | Research Institute For Medicine And Chemistry, Inc. | 2-substituted pregna-1-3,5(10) triene and chola-1,3,5(10) triene derivatives and their biological activity |
-
1999
- 1999-05-11 GB GBGB9910934.0A patent/GB9910934D0/en not_active Ceased
-
2000
- 2000-05-11 DK DK00927569T patent/DK1179005T3/da active
- 2000-05-11 WO PCT/GB2000/001813 patent/WO2000068246A1/en active IP Right Grant
- 2000-05-11 DE DE60006665T patent/DE60006665T2/de not_active Expired - Fee Related
- 2000-05-11 HU HU0201047A patent/HUP0201047A3/hu unknown
- 2000-05-11 JP JP2000616220A patent/JP2002544137A/ja active Pending
- 2000-05-11 PT PT00927569T patent/PT1179005E/pt unknown
- 2000-05-11 CN CNB008095175A patent/CN1158297C/zh not_active Expired - Fee Related
- 2000-05-11 HK HK02105910.4A patent/HK1046001B/en not_active IP Right Cessation
- 2000-05-11 EP EP00927569A patent/EP1179005B1/en not_active Expired - Lifetime
- 2000-05-11 IL IL14644200A patent/IL146442A0/xx active IP Right Grant
- 2000-05-11 NZ NZ515482A patent/NZ515482A/en unknown
- 2000-05-11 ES ES00927569T patent/ES2207509T3/es not_active Expired - Lifetime
- 2000-05-11 CA CA002373443A patent/CA2373443A1/en not_active Abandoned
- 2000-05-11 AU AU45960/00A patent/AU779743B2/en not_active Ceased
- 2000-05-11 AT AT00927569T patent/ATE254629T1/de not_active IP Right Cessation
- 2000-05-11 CZ CZ20014049A patent/CZ297316B6/cs not_active IP Right Cessation
- 2000-05-11 KR KR1020017014382A patent/KR100690040B1/ko not_active Expired - Fee Related
-
2001
- 2001-11-09 ZA ZA200109272A patent/ZA200109272B/xx unknown
- 2001-11-11 IL IL146442A patent/IL146442A/en not_active IP Right Cessation
- 2001-11-12 NO NO20015520A patent/NO319949B1/no not_active IP Right Cessation
-
2003
- 2003-05-11 US US09/926,491 patent/US6881730B1/en not_active Expired - Fee Related
-
2005
- 2005-02-11 US US11/055,620 patent/US20050171075A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60006665T2 (de) | 2004-10-07 |
| IL146442A (en) | 2006-10-05 |
| US20050171075A1 (en) | 2005-08-04 |
| HUP0201047A3 (en) | 2003-07-28 |
| ZA200109272B (en) | 2003-02-26 |
| KR20020013542A (ko) | 2002-02-20 |
| HK1046001A1 (en) | 2002-12-20 |
| HUP0201047A2 (en) | 2002-08-28 |
| AU779743B2 (en) | 2005-02-10 |
| WO2000068246A1 (en) | 2000-11-16 |
| CZ20014049A3 (cs) | 2002-04-17 |
| NZ515482A (en) | 2004-05-28 |
| KR100690040B1 (ko) | 2007-03-09 |
| NO319949B1 (no) | 2005-10-03 |
| EP1179005B1 (en) | 2003-11-19 |
| AU4596000A (en) | 2000-11-21 |
| JP2002544137A (ja) | 2002-12-24 |
| ATE254629T1 (de) | 2003-12-15 |
| US6881730B1 (en) | 2005-04-19 |
| CN1158297C (zh) | 2004-07-21 |
| NO20015520L (no) | 2002-01-09 |
| DE60006665D1 (de) | 2003-12-24 |
| DK1179005T3 (da) | 2004-03-01 |
| CA2373443A1 (en) | 2000-11-16 |
| ES2207509T3 (es) | 2004-06-01 |
| GB9910934D0 (en) | 1999-07-14 |
| PT1179005E (pt) | 2004-04-30 |
| EP1179005A1 (en) | 2002-02-13 |
| HK1046001B (en) | 2004-12-24 |
| NO20015520D0 (no) | 2001-11-12 |
| CN1358193A (zh) | 2002-07-10 |
| CZ297316B6 (cs) | 2006-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL146442A0 (en) | Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy | |
| NZ505348A (en) | 11beta-halogen-7alpha-substituted estratriene derivatives | |
| PL320009A1 (en) | Imidazole derivative | |
| MY125182A (en) | Furanyl insecticide | |
| IE780078L (en) | 11-beta substituted steroids | |
| TW376382B (en) | Arylcycloalkyl derivatives for against inflammatory conditions | |
| MY114174A (en) | Insecticidal tetrahydrofuran-compound | |
| TR199801415T2 (xx) | Se�ici taksanlar,bunlar� haz�rlamak i�in y�ntem ve bunlar�n ila� olarak kullan�m�. | |
| EP0662954A1 (en) | NEW VITAMIN D ANALOGS | |
| IL152728A0 (en) | 2-substituted pregna-1,3,5 (10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity | |
| IE812584L (en) | 3-aminopropoxyphenyl deriatives. | |
| MX9505054A (es) | Derivados de ester de bisfenol. | |
| TW350041B (en) | Bis-depside tertiary alkyl ester derivatives and chemical positive photoresist material | |
| BE904983A (fr) | Acides propenylaminothiazolylcephalosporaniques 3-substitues et leurs esters. | |
| CA2010982A1 (en) | Osteogenesis promotion with use of vitamin d derivatives | |
| NZ231052A (en) | Substituted anthracyclinones and related glycosides | |
| IL104026A0 (en) | Pharmaceutical composition for the improvement of dysuria comprising xanthine derivatives | |
| FR2499076B1 (cs) | ||
| DE69305684D1 (de) | Octahydronaphthalenoxim Derivate für die Inhibierung der Cholesterin Biosynthese, ihre Herstellung und Verwendung | |
| CA1266641C (en) | 16-keto-17-substituted thia-17-alkyl (or alkenyl or alkynyl) androstenes | |
| CA2079466A1 (en) | Novel benzopyran derivatives and an anti-allergic agent possessing the same as the active ingrediant | |
| IE790299L (en) | Testosterone esters | |
| TW345487B (en) | Composition for controlling noxious insects and/or mites comprising an ester compound | |
| MY102457A (en) | Isoquinoline derivatives | |
| ES262486A1 (es) | Procedimiento para la preparaciën de nuevos compuestos n-heterociclicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |